AZTA Financials: Azenta Inc AI Analysis



Financials

AZTA Financial

Azenta Inc

$20.18

3.27%

$0.64

At close: May 22, 16:00:00 GMT-4

$20.18

Post-market: May 22, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$19.54

Open

$19.58

Day's Range

$19.58 - $20.32

52 week range

$17.11 - $41.73

Volume

1.0M

Avg.Volume

959.0K

Dividend yield

EPS (TTM)

-1.26

Market Cap

$929.4M

What is AZTA?

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Features

Markets

News

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	594	148	158	143	143	147
Revenue Growth (YoY)	-8%	1%	-7%	-17%	-10%	-5%
Cost of Revenue	329	84	90	76	77	78
Gross Profit	265	63	67	67	65	68
Selling, General & Admin	248	60	55	61	71	73
Research & Development	33	9	10	6	6	6
Operating Expenses	282	69	66	67	78	79
Other Non Operating Income (Expenses)	0	0	0	0	1	1
Pretax Income	-3	-2	5	3	-10	-5
Income Tax Expense	-32	3	-45	2	7	3
Net Income	-57	-15	50	-52	-40	-13
Net Income Growth	-65%	15%	-1,350%	767%	-71%	-13%
Shares Outstanding (Diluted)	45.92	45.92	45.83	45.82	45.73	45.62
Shares Change (YoY)	1%	1%	-4%	-13%	-18%	-20%
EPS (Diluted)	-1.25	-0.33	1.12	-1.15	-0.88	-0.29
EPS Growth	-65%	14%	-1,179%	825%	-64%	5%
Free Cash Flow	30	14	-5	14	6	22
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	44.61%	42.56%	42.4%	46.85%	45.45%	46.25%
Operating Margin	-2.69%	-4.05%	0.63%	0%	-8.39%	-6.8%
Profit Margin	-9.59%	-10.13%	31.64%	-36.36%	-27.97%	-8.84%
Free Cash Flow Margin	5.05%	9.45%	-3.16%	9.79%	4.19%	14.96%
EBITDA	40	7	15	14	1	8
EBITDA Margin	6.73%	4.72%	9.49%	9.79%	0.69%	5.44%
D&A For EBITDA	56	13	14	14	13	18
EBIT	-16	-6	1	0	-12	-10
EBIT Margin	-2.69%	-4.05%	0.63%	0%	-8.39%	-6.8%
Effective Tax Rate	1,066.66%	-150%	-900%	66.66%	-70%	-60%

Breakdown

TTM

12/31/2025

09/30/2025

06/30/2025

03/31/2025

12/31/2024

Revenue

594

148

158

143

147

Revenue Growth (YoY)

-8%

-7%

-17%

-10%

-5%

Cost of Revenue

329

Gross Profit

265

Selling, General & Admin

248

Research & Development

Operating Expenses

282

Other Non Operating Income (Expenses)

Pretax Income

-3

-2

-10

-5

Income Tax Expense

-32

-45

Net Income

-57

-15

-52

-40

-13

Net Income Growth

-65%

15%

-1,350%

767%

-71%

-13%

Shares Outstanding (Diluted)

45.92

45.83

45.82

45.73

45.62

Shares Change (YoY)

-4%

-13%

-18%

-20%

EPS (Diluted)

-1.25

-0.33

1.12

-1.15

-0.88

-0.29

EPS Growth

-65%

14%

-1,179%

825%

-64%

Free Cash Flow

-5

Free Cash Flow Per Share

Gross Margin

44.61%

42.56%

42.4%

46.85%

45.45%

46.25%

Operating Margin

-2.69%

-4.05%

0.63%

-8.39%

-6.8%

Profit Margin

-9.59%

-10.13%

31.64%

-36.36%

-27.97%

-8.84%

Free Cash Flow Margin

5.05%

9.45%

-3.16%

9.79%

4.19%

14.96%

EBITDA

EBITDA Margin

6.73%

4.72%

9.49%

9.79%

0.69%

5.44%

D&A For EBITDA

EBIT

-16

-6

-12

-10

EBIT Margin

-2.69%

-4.05%

0.63%

-8.39%

-6.8%

Effective Tax Rate

1,066.66%

-150%

-900%

66.66%

-70%

-60%

Follow-Up Questions

What are Azenta Inc's key financial statements?



According to the latest financial statement (Form-10K), Azenta Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for AZTA?



Azenta Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Azenta Inc's revenue broken down by segment or geography?



Azenta Inc largest revenue segment is Multiomics, at a revenue of 269,231,000 in the most earnings release.For geography, North America is the primary market for Azenta Inc, at a revenue of 323,982,000.

Is Azenta Inc profitable?



no, according to the latest financial statements, Azenta Inc has a net loss of $0

Does Azenta Inc have any liabilities?



no, Azenta Inc has liability of 0

How many outstanding shares for Azenta Inc?



Azenta Inc has a total outstanding shares of 0

Azenta Inc (AZTA) Financial

AZTA Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AZTA?

Azenta Inc (AZTA) Financial

AZTA Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AZTA?

AZTA Income

Follow-Up Questions

What are Azenta Inc's key financial statements?

What are the key financial ratios for AZTA?

How is Azenta Inc's revenue broken down by segment or geography?

Is Azenta Inc profitable?

Does Azenta Inc have any liabilities?

How many outstanding shares for Azenta Inc?